Floatz logo

Anti-Psca Monoclonal Antibody Ags-1C4D4

Pancreatic Ductal Adenocarcinoma

Agensys, Inc.monoclonal_antibodyPhase 2Dormant
B
62/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
47/ 100
Competitive Position
89/ 100

Competitive context

280 Active assets in the Pancreatic Ductal Adenocarcinoma cohort.

Asset / SponsorPhaseRating
Immunoglobulin G2, Anti-(Human Ctla-4 (Antigen)) (Human Monoclonal Cp-675206 Clone 11.2.1 Heavy Chain) Disulphide With Human Monoclonal Cp-675206 Clone 11.2.1 Light Chain, Dimer
OHSU Knight Cancer Institute
Phase 2BB
Rmc-6236
Tango Therapeutics, Inc.
Phase 3BB
Daraxonrasib
Revolution Medicines, Inc.
Phase 3BB
S-1
Genentech, Inc.
Phase 2BB
Ivospemin
Panbela Therapeutics, Inc.
Phase 2/3BB

View all 50 →

Same molecule, other indications

Anti-Psca Monoclonal Antibody Ags-1C4D4 is also rated in:

pancreas disorderDormant
B
Indicative · Phase 2
62 / 100
View asset →
pancreatic neoplasmDormant
CCC
Indicative · Phase 2
52 / 100
View asset →
prostate cancerDormant
C
Indicative · Phase 1
39 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →